Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer

Prostate cancer is one of the few malignancies that includes vaccination as a treatment modality. Elements of an effective cancer vaccine should include the ability to elicit a Type I T-cell response and target multiple antigenic proteins expressed early in the disease. Using existing gene datasets...

Descripción completa

Detalles Bibliográficos
Autores principales: Cecil, Denise L., Curtis, Benjamin, Gad, Ekram, Gormley, Michael, Timms, Andrew E., Corulli, Lauren, Bos, Rinke, Damle, Rajendra N., Sepulveda, Manuel A., Disis, Mary L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365795/
https://www.ncbi.nlm.nih.gov/pubmed/35948756
http://dx.doi.org/10.1038/s41598-022-17950-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365795/
https://www.ncbi.nlm.nih.gov/pubmed/35948756
http://dx.doi.org/10.1038/s41598-022-17950-1

Ejemplares similares